These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 30018230

  • 1. Immunogenicity and Induction of Functional Antibodies in Rabbits Immunized with a Trivalent Typhoid-Invasive Nontyphoidal Salmonella Glycoconjugate Formulation.
    Baliban SM, Allen JC, Curtis B, Amin MN, Lees A, Rao RN, Naidu G, Venkatesan R, Rao DY, Mohan VK, Ella KM, Levine MM, Simon R.
    Molecules; 2018 Jul 17; 23(7):. PubMed ID: 30018230
    [Abstract] [Full Text] [Related]

  • 2. Immunogenicity and efficacy following sequential parenterally-administered doses of Salmonella Enteritidis COPS:FliC glycoconjugates in infant and adult mice.
    Baliban SM, Curtis B, Toema D, Tennant SM, Levine MM, Pasetti MF, Simon R.
    PLoS Negl Trop Dis; 2018 May 17; 12(5):e0006522. PubMed ID: 29791435
    [Abstract] [Full Text] [Related]

  • 3. Development of a glycoconjugate vaccine to prevent invasive Salmonella Typhimurium infections in sub-Saharan Africa.
    Baliban SM, Yang M, Ramachandran G, Curtis B, Shridhar S, Laufer RS, Wang JY, Van Druff J, Higginson EE, Hegerle N, Varney KM, Galen JE, Tennant SM, Lees A, MacKerell AD, Levine MM, Simon R.
    PLoS Negl Trop Dis; 2017 Apr 17; 11(4):e0005493. PubMed ID: 28388624
    [Abstract] [Full Text] [Related]

  • 4. Immunogenicity and protective efficacy against Salmonella C2-C3 infection in mice immunized with a glycoconjugate of S. Newport Core-O polysaccharide linked to the homologous serovar FliC protein.
    Schuster O, Sears KT, Ramachandran G, Fuche FJ, Curtis B, Tennant SM, Simon R.
    Hum Vaccin Immunother; 2019 Apr 17; 15(6):1436-1444. PubMed ID: 29873578
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Maternal Antibodies Elicited by Immunization With an O- Polysaccharide Glycoconjugate Vaccine Protect Infant Mice Against Lethal Salmonella Typhimurium Infection.
    Baliban SM, Curtis B, Amin MN, Levine MM, Pasetti MF, Simon R.
    Front Immunol; 2019 Apr 17; 10():2124. PubMed ID: 31555302
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH, Kantele JM, Savolainen LE, Rombo L, Kantele A.
    Vaccine; 2015 Jan 09; 33(3):451-8. PubMed ID: 25433216
    [Abstract] [Full Text] [Related]

  • 10. Differential Killing of Salmonella enterica Serovar Typhi by Antibodies Targeting Vi and Lipopolysaccharide O:9 Antigen.
    Hart PJ, O'Shaughnessy CM, Siggins MK, Bobat S, Kingsley RA, Goulding DA, Crump JA, Reyburn H, Micoli F, Dougan G, Cunningham AF, MacLennan CA.
    PLoS One; 2016 Jan 09; 11(1):e0145945. PubMed ID: 26741681
    [Abstract] [Full Text] [Related]

  • 11. Serum bactericidal assay for the evaluation of typhoid vaccine using a semi-automated colony-counting method.
    Jang MS, Sahastrabuddhe S, Yun CH, Han SH, Yang JS.
    Microb Pathog; 2016 Aug 09; 97():19-26. PubMed ID: 27216239
    [Abstract] [Full Text] [Related]

  • 12. Vi Capsular Polysaccharide Produced by Recombinant Salmonella enterica Serovar Paratyphi A Confers Immunoprotection against Infection by Salmonella enterica Serovar Typhi.
    Xiong K, Zhu C, Chen Z, Zheng C, Tan Y, Rao X, Cong Y.
    Front Cell Infect Microbiol; 2017 Aug 09; 7():135. PubMed ID: 28484685
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of vi-tetanus toxoid conjugated typhoid vaccine (PedaTyph™) in Indian children: School based cluster randomized study.
    Mitra M, Shah N, Ghosh A, Chatterjee S, Kaur I, Bhattacharya N, Basu S.
    Hum Vaccin Immunother; 2016 Apr 02; 12(4):939-45. PubMed ID: 26901576
    [Abstract] [Full Text] [Related]

  • 14. Engineering, conjugation, and immunogenicity assessment of Escherichia coli O121 O antigen for its potential use as a typhoid vaccine component.
    Wetter M, Kowarik M, Steffen M, Carranza P, Corradin G, Wacker M.
    Glycoconj J; 2013 Jul 02; 30(5):511-22. PubMed ID: 23053636
    [Abstract] [Full Text] [Related]

  • 15. In vitro characterization and preclinical immunogenicity of Typhax, a typhoid fever protein capsular matrix vaccine candidate.
    Griffin TJ, Thanawastien A, Cartee RT, Mekalanos JJ, Killeen KP.
    Hum Vaccin Immunother; 2019 Jul 02; 15(6):1310-1316. PubMed ID: 31021700
    [Abstract] [Full Text] [Related]

  • 16. Strain Selection for Generation of O-Antigen-Based Glycoconjugate Vaccines against Invasive Nontyphoidal Salmonella Disease.
    Lanzilao L, Stefanetti G, Saul A, MacLennan CA, Micoli F, Rondini S.
    PLoS One; 2015 Jul 02; 10(10):e0139847. PubMed ID: 26445460
    [Abstract] [Full Text] [Related]

  • 17. Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials.
    Bhutta ZA, Capeding MR, Bavdekar A, Marchetti E, Ariff S, Soofi SB, Anemona A, Habib MA, Alberto E, Juvekar S, Khan RM, Marhaba R, Ali N, Malubay N, Kawade A, Saul A, Martin LB, Podda A.
    Lancet Infect Dis; 2014 Feb 02; 14(2):119-29. PubMed ID: 24290843
    [Abstract] [Full Text] [Related]

  • 18. Comparative immunogenicity and efficacy of equivalent outer membrane vesicle and glycoconjugate vaccines against nontyphoidal Salmonella.
    Micoli F, Rondini S, Alfini R, Lanzilao L, Necchi F, Negrea A, Rossi O, Brandt C, Clare S, Mastroeni P, Rappuoli R, Saul A, MacLennan CA.
    Proc Natl Acad Sci U S A; 2018 Oct 09; 115(41):10428-10433. PubMed ID: 30262653
    [Abstract] [Full Text] [Related]

  • 19. A candidate glycoconjugate vaccine induces protective antibodies in the serum and intestinal secretions, antibody recall response and memory T cells and protects against both typhoidal and non-typhoidal Salmonella serovars.
    Haldar R, Dhar A, Ganguli D, Chakraborty S, Pal A, Banik G, Miyoshi SI, Das S.
    Front Immunol; 2023 Oct 09; 14():1304170. PubMed ID: 38264668
    [Abstract] [Full Text] [Related]

  • 20. Safety and immunogenicity of a Vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 study.
    Mohan VK, Varanasi V, Singh A, Pasetti MF, Levine MM, Venkatesan R, Ella KM.
    Clin Infect Dis; 2015 Aug 01; 61(3):393-402. PubMed ID: 25870324
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.